The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AADI BIOSCIENCES INC COM 00032Q104   3,809,768 1,849,402 SH   SOLE   1,849,402 0 0
ACELYRIN INC COM 00445A100   1,794,520 364,000 SH   SOLE   364,000 0 0
ARCELLX INC COMMON STOCK 03940C100   5,185,971 62,100 SH   SOLE   62,100 0 0
ARGENX SE SPONSORED ADR 04016X101   3,198,272 5,900 SH   SOLE   5,900 0 0
ARTIVA BIOTHERAPEUTICS INC COM 04317A107   679,800 44,000 SH   SOLE   44,000 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101   3,135,510 21,000 SH   SOLE   21,000 0 0
BENITEC BIOPHARMA INC COM NEW 08205P209   273,862 29,800 SH   SOLE   29,800 0 0
CELCUITY INC COM 15102K100   694,806 46,600 SH   SOLE   46,600 0 0
CLIMB BIO INC COM 28658R106   274,860 54,000 SH   SOLE   54,000 0 0
COMPASS PATHWAYS PLC SPONSORED ADS 20451W101   2,434,950 386,500 SH   SOLE   386,500 0 0
CORBUS PHARMACEUTICALS HOLDINGS COM NEW 21833P301   381,655 18,500 SH   SOLE   18,500 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107   6,729,870 131,700 SH   SOLE   131,700 0 0
DYNE THERAPEUTICS INC COM 26818M108   1,659,504 46,200 SH   SOLE   46,200 0 0
EDGEWISE THERAPEUTICS INC COM 28036F105   1,681,470 63,000 SH   SOLE   63,000 0 0
ENLIVEN THERAPEUTICS INC COM 29337E102   7,569,239 296,368 SH   SOLE   296,368 0 0
GERON CORP COM 374163103   703,246 154,900 SH   SOLE   154,900 0 0
GILEAD SCIENCES INC COM 375558103   1,634,880 19,500 SH   SOLE   19,500 0 0
HELIX ACQUISITION CORP II CL A ORD SHS G4444H101   1,890,857 180,945 SH   SOLE   180,945 0 0
INSMED INC COM PAR $.01 457669307   7,847,500 107,500 SH   SOLE   107,500 0 0
KURA ONCOLOGY INC. COMMON STOCK COM 50127T109   3,849,380 197,000 SH   SOLE   197,000 0 0
LEAP THERAPEUTICS INC COM NEW 52187K200   309,685 120,500 SH   SOLE   120,500 0 0
LIQUIDIA CORPORATION COM NEW 53635D202   735,000 73,500 SH   SOLE   73,500 0 0
MEREO BIOPHARMA GROUP PLC SPON ADS 589492107   5,181,477 1,260,700 SH   SOLE   1,260,700 0 0
MERSANA THERAPEUTICS INC COM 59045L106   2,268,000 1,200,000 SH   SOLE   1,200,000 0 0
NUVATION BIO INC -CW27 *W EXP 07/07/2027 67080N119   8,892 90,832 SH   SOLE   90,832 0 0
OCULAR THERAPEUTIX INC COM 67576A100   10,353,618 1,190,071 SH   SOLE   1,190,071 0 0
PRAXIS PRECISION MEDICINES I COM 74006W207   3,308,550 57,500 SH   SOLE   57,500 0 0
RAPPORT THERAPEUTICS INC COM 75383L102   360,448 17,600 SH   SOLE   17,600 0 0
REVOLUTION MEDICINES INC COM 76155X100   4,897,800 108,000 SH   SOLE   108,000 0 0
ROCKET PHARMACEUTICALS INC COM 77313F106   3,509,300 190,000 SH   SOLE   190,000 0 0
TAYSHA GENE THERAPIES INC COM SHS 877619106   4,259,174 2,118,992 SH   SOLE   2,118,992 0 0
TECTONIC THERAPEUTIC INC COM 878972108   415,110 13,700 SH   SOLE   13,700 0 0
TERNS PHARMACEUTICALS INC COM 880881107   4,061,580 487,000 SH   SOLE   487,000 0 0
THIRD HARMONIC BIO INC COM 88427A107   210,133 15,508 SH   SOLE   15,508 0 0
TOURMALINE BIO INC COM 89157D105   8,538,162 332,095 SH   SOLE   332,095 0 0
TRAVERE THERAPEUTICS INC COM 89422G107   265,810 19,000 SH   SOLE   19,000 0 0
TREVI THERAPEUTICS INC COM 89532M101   970,270 290,500 SH   SOLE   290,500 0 0
ULTRAGENYX PHARMACEUTICAL INC COM 90400D108   1,394,305 25,100 SH   SOLE   25,100 0 0
UNICYCIVE THERAPEUTICS INC COM 90466Y103   807,315 1,979,199 SH   SOLE   1,979,199 0 0
VAXCYTE INC COM 92243G108   15,472,158 135,400 SH   SOLE   135,400 0 0
VERVE THERAPEUTICS INC COM 92539P101   707,124 146,100 SH   SOLE   146,100 0 0